Purchase
Description
Matuzumab biosimilar is a humanized IgG1 monoclonal antibody against human EGFR. As it only has approximately 10% murine origin it has limited immunogenicity, and being IgG1 it is capable of inducing antibody dependent cell cytotoxicity (ADCC).Matuzumab biosimilar is produced in mammalian (Chinese hamster ovary) cell culture.
Matuzumab biosimilar is supplied at a
concentration of 10 mg/mL as a sterile, preservative-free, non-pyrogenic, clear,
colorless liquid, which contains 20mM Tris buffered
saline and Water for Injection.
Statement: this product is used for R&D only, not for clinical usage.
Properties
|
Name
|
Matuzumab biosimilar
|
|
CAS
NO.
|
339186-68-4
|
|
Type
|
Whole
antibody
|
|
Source
|
Humanized
|
|
Target
|
EGFR
|
|
Clone
|
Monoclone
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508154346004600.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Matuzumab
|
